Homo sapiens IRCHF5B breast and ovarian cancer susceptibility protein - Nucleotide

Run BLAST
Find regions of similarity between this sequence and other sequences using BLAST.
Pick Primers
Design and test primers for this sequence using Primer-BLAST.

Cell fixation improves performance of in situ crosslinking mass spectrometry while preserving cellular ultrastructure. [Nat Commun. 2024]
Cell fixation improves performance of in situ crosslinking mass spectrometry while preserving cellular ultrastructure.
Michael ARM, Amaral BC, Ball KL, Eiriksson KH, Schriemer DC. Nat Commun. 2024 Oct 2; 15(1):8537. Epub 2024 Oct 2.
Hypermethylation of the BRCA2 gene promoter and its co-hypermethylation with the BRCA1 gene promoter in patients with breast cancer. [Cancer Biomark. 2024]
Hypermethylation of the BRCA2 gene promoter and its co-hypermethylation with the BRCA1 gene promoter in patients with breast cancer.
Fishchuk L, Rossokha Z, Lobanova O, Cheshuk V, Vereshchako R, Vershyhora V, Medvedieva N, Dubitskaa O, Gorovenko N. Cancer Biomark. 2024; 40(3-4):275-283.
Incidence of endometrial cancer in BRCA mutation carriers. [Gynecol Oncol. 2024]
Incidence of endometrial cancer in BRCA mutation carriers.
Kotsopoulos J, Lubinski J, Huzarski T, Bychkovsky BL, Moller P, Kim RH, Tung N, Eisen A, Foulkes W, Singer CF, et al. Gynecol Oncol. 2024 Oct; 189:148-155. Epub 2024 Aug 21.

RefSeq alternative splicing
See 6 reference mRNA sequence splice variants for the BRCA2 gene.

Your browsing activity is empty.

Activity recording is turned off.

Nucleotide